Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Stem Cells for Corneal Diseases
NCT04484402Phase 2Completed
- Start
- Oct 2016
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in corneal ulcer, Corneal dystrophy, keratitis, Corneal burn, Corneal epithelial defect. Started Oct 2016; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
corneal ulcerCorneal dystrophykeratitisCorneal burnCorneal epithelial defect
Beyond the preview
Go deeper on NCT04484402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04484402.